DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Raxibacumab
Raxibacumab
AHFS Pharmacologic-Therapeutic Classification System
Pdf
Phage Display-Based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed Against Human Pathogens
The Effect of Raxibacumab on the Immunogenicity of Anthrax Vaccine Adsorbed: a Phase
A Review of the Efficacy of FDA-Approved B. Anthracis Anti
RAXIBACUMAB Safely and Effectively
Studies on Antitoxin Use for Postexposure Prophylaxis (PEP)
Boosting Anti-Infective Antibody and Vaccine Development
1 Supplementary Materials 1 2 Data Sources 3 in Total, 60 Antibodies
Monoclonal Antibodies for Infectious Diseases
Raxibacumab: a Panacea for Anthrax Disease?
(INN) for Biological and Biotechnological Substances
Pharmacology and Anti-Infective Role of Raxibacumab: a Novel Monoclonal Antibody for the Treatment of Anthrax H Singh1, S Ratol2, P Thangaraju3, S Kumar1, a Goel4
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
HHS Public Access Author Manuscript
VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1- Exposed Infants
Development and Challenges to Monoclonal Antibodies for Passive Immunization
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Top View
© Copyright 2018 Dennis Ryan Goulet
History and Practice: Antibodies in Infectious Diseases ADAM HEY1 1Preclinical Safety, Biologics, Novartis AG, Basel, Switzerland
Development of Therapeutic Antibodies for the Treatment Of
Wo 2010/095940 A2
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2018
Assessment Report
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Anthrax Immune Globulin Improves Hemodynamics and Survival During B
Cross Discipline Team Leader Review
Monoclonal Antibody Consumption Pattern in a Sponsored Tertiary-Care Healthcare System in a Developing Country: a Five-Year Study from 2013 - 2017
Evaluating the Need for an Orphan Drug Act in India by Comparing It with the US Orphan
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
Raxibacumab: Potential Role in the Treatment of Inhalational Anthrax
AHFS Pharmacologic-Therapeutic Classification System
Biological Product Deviation Reporting and HCT/P Deviation Reporting – Non-Blood Product Codes
(INN) for Biological and Biotechnological Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Anticorps Monoclonaux En Infectiologie Des Nouveaux Partenaires Dans L'arsenal Thérapeutique
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
DEPARTMENT of HEALTH and HUMAN SERVICES
Mrna Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
Monoclonal Antibodies